Angiogenic Pathway Activation Multi-Component Blood Vessel Formation Multiple components contribute to comprehensive angiogenesis through distinct but complementary mechanisms[5]: BPC-157 upregulates VEGFR2 expression and enhances endothelial cell proliferation TB-500 promotes endothelial cell migration and tube formation GHK-Cu stimulates angiogenic growth factor expression and vessel maturation Combined effects result in robust tissue vascularization and nutrient delivery Improved collateral circulation development in ischemic conditions Nitric Oxide System Modulation Vascular Protection BPC-157 influences nitric oxide signaling pathways to support vascular function[6]: Enhanced eNOS phosphorylation leading to controlled NO production Modulation of blood flow and vascular tone Protection against both NO excess and NO deficiency states Coordination with angiogenic effects for comprehensive vascular support Synergistic Advantage: KLOW Blends four-pathway approach enables simultaneous activation of cellular migration (BPC-157/TB-500), matrix synthesis and gene expression modulation (GHK-Cu), robust inflammation control (KPV), and comprehensive angiogenesis
Firstly, given the evidence that glutathione and glutamate levels in the brain are affected by a risk variant of the gene coding for the glutathione synthesis enzyme, the role of genetic influences should be investigated [22]
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
They seem like they could work
In light of clinical evidence suggesting elevated glutamate in OCD, summarized above, elevating glial glutamate efflux may not be desirable indeed, this is the opposite of the proposed mechanism of riluzole in enhancing reuptake of extrasynaptic glutamate (Pittenger, Coric et al., 2008)
